title: [Periprocedural management of hemostasis risk in interventional radiology].
abstract: Given the increasing demand for interventional image-guided procedures, radiologists are increasingly sollicited by clinicians to participate in the management of patients prior to and after the interventional procedure, especially with regards to hemostasis. Therefore, radiologists should be familiar with the risk of procedure related hemorrhage. Based on consensus guidelines published by the Society of Interventional Radiology (SIR), the risk of hemorrhage for each interventional procedure will be classified. Recommendations for preprocedure testing based on the type of procedure planned will be reviewed. Finally, limitations of hemostasis parameters will be discussed along with management of anticoagulants and antiplatelet agents before the procedure.
authors.affiliation: Service de radiologie, hôpital d'instruction des armées Percy, 101, avenue Henri-Barbusse, 92140 Clamart, France. potet_julien@yahoo.fr
authors.forename: J
authors.initials: J
authors.lastname: Potet
authors.forename: G
authors.initials: G
authors.lastname: Weber-Donat
authors.forename: A
authors.initials: A
authors.lastname: Thome
authors.forename: L
authors.initials: L
authors.lastname: Valbousquet
authors.forename: E
authors.initials: E
authors.lastname: Peroux
authors.forename: J
authors.initials: J
authors.lastname: Konopacki
authors.forename: J
authors.initials: J
authors.lastname: Baccialone
authors.forename: C-A
authors.initials: CA
authors.lastname: Teriitehau
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D006470:Hemorrhage / Q000209:etiology* / Q000628:therapy*; D006489:Hemostatic Techniques; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D010976:Platelet Count; D017410:Practice Guidelines as Topic; D011300:Preoperative Care; D015642:Radiology, Interventional / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors